MetaCap

Gain Therapeutics Insider Trades

NASDAQ: GANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.9994-0.0506 (-4.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Gain Therapeutics insider activity

No Gain Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Mack Gene (CFO and Interim CEO) buying 14,400 shares at $1.01 on Aug 9, 2024. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GANX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GANX insider transactions

Gain Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Aug 9, 2024Islam KhalidExecutive ChairmanBuy50,000$49.94KForm 4
Aug 9, 2024Mack GeneCFO and Interim CEOBuy14,400$14.54KForm 4
Jul 1, 2024RICHMAN ERIC IDirectorBuy12,000$14.52KForm 4
Jul 1, 2024RICHMAN ERIC IDirectorBuy5,000$6.15KForm 4
Mar 28, 2024Riley Jeffrey ScottDirectorBuy30,000$115.77KForm 4
Mar 26, 2024Alder MatthiasChief Executive OfficerTax withholding6,085$24.71KForm 4
Mar 26, 2024Alder MatthiasChief Executive OfficerOption exercise637—Form 4
Mar 26, 2024Alder MatthiasChief Executive OfficerOption exercise825—Form 4
Mar 26, 2024Alder MatthiasChief Executive OfficerOption exercise18,750—Form 4
Dec 21, 2023Alder MatthiasChief Executive OfficerSale206$506.76Form 4
Dec 20, 2023Alder MatthiasChief Executive OfficerOption exercise637—Form 4
Dec 7, 2023Alder MatthiasChief Executive OfficerSale1,820$4.55KForm 4
Oct 1, 2023Alder MatthiasChief Executive OfficerOption exercise825—Form 4
Sep 20, 2023Alder MatthiasChief Executive OfficerOption exercise2,550—Form 4
Sep 20, 2023RICHMAN ERIC IDirectorOption exercise54,900—Form 4
Jul 1, 2023Alder MatthiasChief Executive OfficerOption exercise3,300—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related